Back to today’s briefing

Story perspectives

NHS Introduces Game-Changing Blood Test for Cancer Treatment

5/31/2025

34 5

Summary

Story summary

NHS England is set to revolutionize cancer care with a pioneering "liquid biopsy" blood test for lung and breast cancer patients. This innovative test detects tumor DNA, allowing doctors to make treatment decisions up to two weeks sooner. Annually, 15,000 lung and 5,000 breast cancer patients will gain access to targeted therapies, potentially saving the NHS £11 million in care costs.

1 of 1

Story summary

NHS England is set to revolutionize cancer care with a pioneering "liquid biopsy" blood test for lung and breast cancer patients. This innovative test detects tumor DNA, allowing doctors to make treatment decisions up to two weeks sooner. Annually, 15,000 lung and 5,000 breast cancer patients will gain access to targeted therapies, potentially saving the NHS £11 million in care costs.